RU2018137206A3 - - Google Patents

Download PDF

Info

Publication number
RU2018137206A3
RU2018137206A3 RU2018137206A RU2018137206A RU2018137206A3 RU 2018137206 A3 RU2018137206 A3 RU 2018137206A3 RU 2018137206 A RU2018137206 A RU 2018137206A RU 2018137206 A RU2018137206 A RU 2018137206A RU 2018137206 A3 RU2018137206 A3 RU 2018137206A3
Authority
RU
Russia
Application number
RU2018137206A
Other languages
Russian (ru)
Other versions
RU2751767C3 (ru
RU2751767C2 (ru
RU2018137206A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58549282&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2018137206(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2018137206A publication Critical patent/RU2018137206A/ru
Publication of RU2018137206A3 publication Critical patent/RU2018137206A3/ru
Application granted granted Critical
Publication of RU2751767C2 publication Critical patent/RU2751767C2/ru
Publication of RU2751767C3 publication Critical patent/RU2751767C3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
RU2018137206A 2017-04-04 Жидкие составы (s)-n-(5-((r)-2-(2,5-дифторфенил)пирролидин-1-ил)пиразоло[1,5-a]пиримидин-3-ил)-3-гидроксипирролидин-1-карбоксамида RU2751767C3 (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662318041P 2016-04-04 2016-04-04
US62/318,041 2016-04-04
US201662323452P 2016-04-15 2016-04-15
US62/323,452 2016-04-15
US201662329561P 2016-04-29 2016-04-29
US62/329,561 2016-04-29
PCT/US2017/025939 WO2017176751A1 (en) 2016-04-04 2017-04-04 Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide

Publications (4)

Publication Number Publication Date
RU2018137206A RU2018137206A (ru) 2020-05-12
RU2018137206A3 true RU2018137206A3 (enExample) 2020-07-28
RU2751767C2 RU2751767C2 (ru) 2021-07-16
RU2751767C3 RU2751767C3 (ru) 2025-04-04

Family

ID=

Also Published As

Publication number Publication date
CA3019671A1 (en) 2017-10-12
AU2017246554B2 (en) 2022-08-18
US20200338079A1 (en) 2020-10-29
DK3439662T3 (da) 2024-09-02
TWI746537B (zh) 2021-11-21
RS65987B1 (sr) 2024-10-31
CN109414442A (zh) 2019-03-01
JP2019511575A (ja) 2019-04-25
TN2018000335A1 (en) 2020-01-16
PT3439662T (pt) 2024-09-30
US20170296544A1 (en) 2017-10-19
SI3439662T1 (sl) 2024-11-29
CA3019671C (en) 2024-02-20
HUE068971T2 (hu) 2025-02-28
ECSP18083443A (es) 2019-07-31
IL304018A (en) 2023-08-01
ES2987474T3 (es) 2024-11-15
PL3439662T3 (pl) 2024-10-28
EP3439662B1 (en) 2024-07-24
MA44610A (fr) 2019-02-13
CO2018010761A2 (es) 2018-10-22
MX386416B (es) 2025-03-18
CL2018002806A1 (es) 2019-03-01
UA125026C2 (uk) 2021-12-29
HRP20241282T1 (hr) 2024-12-06
NI201800102A (es) 2019-02-15
KR102400423B1 (ko) 2022-05-19
RU2751767C2 (ru) 2021-07-16
CN109414442B (zh) 2024-03-29
AU2017246554A1 (en) 2018-11-01
CR20180501A (es) 2019-04-05
US11484535B2 (en) 2022-11-01
FI3439662T3 (fi) 2024-09-04
US10137127B2 (en) 2018-11-27
PE20181888A1 (es) 2018-12-11
CU20180125A7 (es) 2019-05-03
LT3439662T (lt) 2024-10-10
SG11201808559PA (en) 2018-10-30
MX2018012163A (es) 2019-07-08
TW201801730A (zh) 2018-01-16
PH12018502124A1 (en) 2019-08-19
GEAP202114914A (en) 2021-08-25
PH12018502124B1 (en) 2024-04-12
JP7061602B2 (ja) 2022-04-28
US20190216814A1 (en) 2019-07-18
RU2018137206A (ru) 2020-05-12
NZ747135A (en) 2025-05-02
KR20180128484A (ko) 2018-12-03
DOP2018000214A (es) 2019-01-15
GEP20227339B (en) 2022-01-25
WO2017176751A1 (en) 2017-10-12
US10668072B2 (en) 2020-06-02
IL262003A (en) 2018-10-31
SA518400168B1 (ar) 2022-11-09
CL2019002238A1 (es) 2019-12-27
BR112018070304A2 (pt) 2019-01-29
EP3439662A1 (en) 2019-02-13

Similar Documents

Publication Publication Date Title
BR112019002665A2 (enExample)
BR112018004986A2 (enExample)
BR112019001429A2 (enExample)
BR112019009192A2 (enExample)
BR212018070320U2 (enExample)
BR112019009210A2 (enExample)
BR112019011044B1 (pt) Compostos de pirazol substituído, seu uso, e composição farmacêutica
BR112019008501B1 (pt) Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador
BR112019003116B1 (pt) Configuração de símbolo de rajada comum de uplink
BR112019001236B1 (pt) Método para executar uma função suplementar para uma consulta de linguagem natural apresentada a um aplicativo de orientação de mídia interativa
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112019006736A2 (enExample)
BR112019003108A2 (enExample)
CN303646078S (zh) 包装盒(国剑-抗战胜利纪念版151)
CN303648710S (zh) 宠物玩具(飞盘跑轮)
CN303585717S (zh) 手持式挂烫机(yb-858)
CN303645379S (zh) 小刀(10)
CN303629545S (zh) 户外通信机柜
CN303577526S (zh) 含片包装盒(乐旁松露外包装盒)
CN303641272S (zh) 躯干模型
CN303606664S (zh) 燃烧炉(便携式)
CN303606598S (zh) 集便系统污物箱(crh380型简统车)
CN303536045S (zh) 嫁衣(15)